Source:http://linkedlifedata.com/resource/pubmed/id/12944043
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-8-28
|
pubmed:abstractText |
Sixty-four Romney ewe lambs were allocated to 12 groups on the basis of liveweight. Four groups (n=5) were administered oral ivermectin (IVM), 4 (n=6) oral moxidectin (MOX) and the remaining 4 (n=5) controlled-release capsules containing IVM (IVM-CRCs). Nine and 10 days later, the groups within each treatment type were challenged with infective-stage larvae (L3) of 1 of 4 different isolates of Teladorsagia circumcincta (two doses each of 5000 L3). The first of these (S) was known to be anthelmintic-susceptible; the second (OR) was a multiple anthelmintic-resistant strain recovered from the field following therapeutic failure of both ivermectin and moxidectin and subsequently maintained in the laboratory without further anthelmintic selection; the third (R) was derived from OR but had been passaged for five generations indoors with each generation being screened with all three broad-spectrum anthelmintic classes; and the fourth (RxS) was an F1 cross between the R and S isolates. As anticipated, because of its limited residual activity, IVM had no significant effect on the establishment, 9 and 10 days post-treatment, of any of the parasite isolates. In contrast MOX, which has greater residual activity, was highly effective at preventing the establishment of the S isolate but showed no significant effect against the OR, R or RxS isolates. The IVM-CRC was also highly effective at preventing the establishment of the S isolate and furthermore it significantly reduced establishment of both the OR and RxS isolates, although it had no significant effect against the R isolate. The results suggest that with respect to the establishment of T. circumcincta L3s following anthelmintic treatment, macrocyclic lactone (ML) resistance is effectively a dominant trait in the presence of MOX, while it behaves as a partially dominant/recessive trait under treatment with IVM-CRCs. The potential implications of this finding in relation to selection for ML resistance in T. circumcincta are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anthelmintics,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Ivermectin,
http://linkedlifedata.com/resource/pubmed/chemical/Macrolides,
http://linkedlifedata.com/resource/pubmed/chemical/milbemycin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0304-4017
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
115
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
301-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12944043-Abomasum,
pubmed-meshheading:12944043-Administration, Oral,
pubmed-meshheading:12944043-Animals,
pubmed-meshheading:12944043-Anthelmintics,
pubmed-meshheading:12944043-Delayed-Action Preparations,
pubmed-meshheading:12944043-Drug Resistance,
pubmed-meshheading:12944043-Feces,
pubmed-meshheading:12944043-Female,
pubmed-meshheading:12944043-Intestinal Diseases, Parasitic,
pubmed-meshheading:12944043-Ivermectin,
pubmed-meshheading:12944043-Macrolides,
pubmed-meshheading:12944043-Ostertagia,
pubmed-meshheading:12944043-Ostertagiasis,
pubmed-meshheading:12944043-Parasite Egg Count,
pubmed-meshheading:12944043-Random Allocation,
pubmed-meshheading:12944043-Sheep,
pubmed-meshheading:12944043-Sheep Diseases
|
pubmed:year |
2003
|
pubmed:articleTitle |
Resistance to prophylactic treatment with macrocyclic lactone anthelmintics in Teladorsagia circumcincta.
|
pubmed:affiliation |
AgResearch, Grasslands Research Centre, Private Bag 11008, Palmerston North, New Zealand. ian.sutherland@csiro.au
|
pubmed:publicationType |
Journal Article
|